4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-23-000035
President and CEO sold 41,070 shares at an average $1.13 ($46,501)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brunn Carsten President and CEO | 2023-01-04 | Sale | −27,549 | $1.13 | $31,232 | 799,534 | D: show line 1 in the form |
| Brunn Carsten President and CEO | 2023-01-04 | Sale | −48 | $1.15 | $55 | 799,486 | D: show line 2 in the form |
| Brunn Carsten President and CEO | 2023-01-05 | Sale | −13,396 | $1.13 | $15,128 | 786,090 | D: show line 3 in the form |
| Brunn Carsten President and CEO | 2023-01-05 | Sale | −77 | $1.12 | $86 | 786,013 | D: show line 4 in the form |
| Open-market sales · 41,070 sh · avg $1.13 · $46,501 | |||||||
Loading xslF345X03/wf-form4_167304337502065.xml…